Search results for "Cognitive disorder"

showing 10 items of 78 documents

Insight into epileptic and physiological déjà vu: from a multicentric cohort study

2019

Background and purpose The presence of a continuum between physiological deja vu (DV) and epileptic DV is still not known as well as epidemiological data in the Italian population. The aim was to identify the epidemiological distribution of DV in Italy, and secondly to look for specific features of DV able to discriminate between epileptic and non-epileptic DV. Methods In all, 1000 individuals, 543 healthy controls (C) (313 women; age 40 ± 15 years) and 457 patients with epilepsy (E) (260 women; age 39 ± 14 years), were prospectively recruited from 10 outpatient neurological clinics throughout Italy. All populations were screened using the Italian Inventory for Deja Vu Experiences Assessmen…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectNeurocognitive Disordersepilepsy; epileptic déjà vu; physiological déjà vu; Adult; Cohort Studies; Epilepsy; Female; Humans; Italy; Male; Middle Aged; Neurocognitive Disorders; Recognition Psychology; Deja VuCohort Studies03 medical and health sciencesEpilepsy0302 clinical medicineEpidemiologyHumansPsychologyMedicine030212 general & internal medicinePsychiatrymedia_commonbusiness.industryphysiological déjà vuRecognition PsychologyMiddle AgedDeja Vumedicine.diseaseItalian populationepileptic déjà vuRecognitionItalyNeurologyFeelingDéjà vuEtiologyepilepsyFemaleNeurology (clinical)Epileptic seizuremedicine.symptombusiness030217 neurology & neurosurgeryCohort study
researchProduct

Living with acquired brain injury: Self-concept as mediating variable in the adjustment process

2010

Sequelae of acquired brain injury (ABI) require adjustment processes in which survivors must strive to regain subjective well-being (SWB) in the face of chronic impairment. The current study investigates whether the self-concept of achievement mediates this process. Thirty-five post-acute patients with ABI were assessed neuropsychologically for performance in memory, attention, concept formation and reasoning. Data concerning subjective complaints in applied cognition, self-concept, and SWB were collected. Patients rated their self-concept more negatively compared to a normative sample. Effects of subjective complaints in applied cognition on SWB were mediated by the self-concept of achieve…

AdultMalemedicine.medical_treatmentmedia_common.quotation_subjectPoison controlNeuropsychological TestsDevelopmental psychologyCognitionArts and Humanities (miscellaneous)MemoryAdaptation PsychologicalmedicineHumansPersonalityAttentionAcquired brain injuryApplied Psychologymedia_commonRehabilitationRehabilitationCognitive disorderNeuropsychologyCognitionAchievementmedicine.diseaseSelf ConceptNeuropsychology and Physiological PsychologyBrain InjuriesPsychological well-beingFemaleCognition DisordersPsychologyNeuropsychological Rehabilitation
researchProduct

Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations

2001

The prevalence and pattern of cognitive impairment in systemic lupus erythematosus (SLE) patients with (NPSLE) and without (nSLE) overt neuropsychiatric manifestations were investigated. Fifty-two nSLE patients, 23 NPSLE patients and 27 healthy controls were evaluated with a battery of standardized neuropsychological and psychological tests. Disease duration, disease activity index, and current corticosteroid therapy were collected. Cognitive impairment was identified in 14 (26.9%) and in 12 (52.2%) of subjects with nSLE and NPSLE, respectively. Both SLE groups showed a significant impairment compared with controls on tasks assessing verbal and non-verbal long-term memory, and visuoconstruc…

Adultmedicine.medical_specialtyAnxietyNeuropsychological TestsMental ProcessesAdrenal Cortex HormonesMemoryInternal medicinemedicineHumansLupus Erythematosus SystemicSpeechSystemic lupus erythematosus Neuropsychiatric SLE Cognitive impairment Neuropsychology DepressionAttentionPsychological testingEffects of sleep deprivation on cognitive performanceDepression (differential diagnoses)Psychiatric Status Rating ScalesLupus erythematosusDepressionCognitive disorderNeuropsychologymedicine.diseaseConnective tissue diseaseMemory Short-TermNeurologyMental RecallPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)Cognition DisordersPsychologyPsychomotor PerformancePsychopathologyJournal of the Neurological Sciences
researchProduct

Assessment of frontal lobe functioning in schizophrenia and unipolar major depression.

1993

This study has used neuropsychological tasks – Wisconsin Card Sort (WCST), Trail Making (TMT) A and B, Verbal Fluency, Digit Span – to compare acute and currently off-medication schizophrenics, patients with unipolar nonpsychotic major depression and healthy controls. Both patient groups differed significantly from healthy controls in their neuropsychological performance. Furthermore there was only little (quantitative) difference between schizophrenics and depressed patients in the frontal lobe associated tasks: WCST, TMT and Verbal Fluency. Depressed patients tended to perform worse than schizophrenics on Digit Span, a task hypothesized to involve other than frontal areas of the brain. Al…

Adultmedicine.medical_specialtyPsychosisAudiologyNeuropsychological Testsbehavioral disciplines and activitiesSeverity of Illness IndexmedicineMemory spanVerbal fluency testHumansPsychiatryDepressive Disordermedicine.diagnostic_testCognitive disorderNeuropsychologyNeuropsychological testMiddle Agedmedicine.diseaseFrontal LobePsychiatry and Mental healthClinical PsychologyFrontal lobeSchizophreniaSchizophreniaSchizophrenic PsychologyPsychologyPsychopathology
researchProduct

Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis

2004

BACKGROUND: Cognitive impairment may occur at any time during the course of multiple sclerosis (MS), and it is often a major cause of disability in patients with the disease. The APOE-epsilon4 allele is the major known genetic risk factor for late onset familial and sporadic Alzheimer's Disease (AD), and it seems to be implicated in cognitive decline in normal elderly persons. OBJECTIVE: To investigate the clinical and genetic variables that can be associated with the cognitive decline in patients with MS. METHODS: Five-hundred and three patients with clinically definite MS underwent a battery of neuropsychological tests and, according to the number of failed tests, were divided into cognit…

Apolipoprotein EAdultMalemedicine.medical_specialtyPediatricsNeurologyMultiple SclerosisMessengerLate onsetDiseaseNeuropsychological TestsApolipoproteins EmedicineOdds RatioHumansRNA MessengerCognitive declineAllelePsychiatrycognitive impairmentAPOE; Cognitive impairment; Multiple sclerosisAnalysis of VarianceSex CharacteristicsChi-Square DistributionReverse Transcriptase Polymerase Chain ReactionMultiple sclerosisCognitive disorderGenetic VariationMiddle Agedmedicine.diseasemultiple sclerosis cognitive impairment gender geneticNeurologyGenetic Variation; Odds Ratio; Analysis of Variance; Sex Characteristics; Chi-Square Distribution; Humans; Apolipoproteins E; Reverse Transcriptase Polymerase Chain Reaction; Cognition Disorders; RNA Messenger; Multiple Sclerosis; Adult; Middle Aged; Neuropsychological Tests; Female; MaleRNAFemaleSettore MED/26 - NeurologiaNeurology (clinical)Psychologymultiple sclerosis · cognitive impairment · APOECognition DisordersAPOE
researchProduct

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder

2009

Recent data show that biomarkers differ in early and late-stage bipolar disorder (BD). Here we propose a model of staging for bipolar disorder that emphasizes the potential use of biomarkers for differentiating early and late-stage BD patients in the inter-episodic period. The proposed model includes a Latent phase: patients at "ultra-high-risk" for developing BD, characterized by a family history of BD, temperament traits, mood, and anxiety symptoms as well as genetic vulnerability for developing the disorder; Stage I: patients who return to their baseline level of functioning when mood episodes resolve; Stage II: biomarkers and functioning impairment are related to comorbidities or rapid-…

Bipolar Disordermedia_common.quotation_subjectAnxietyModels BiologicalRisk FactorsmedicineHumansNerve Growth FactorsBipolar disorderFamily historyTemperamentBiological Psychiatrymedia_commonPharmacologyCognitive disorderCognitionmedicine.diseaseAffectMoodDisease ProgressionCytokinesAnxietyTemperamentmedicine.symptomCognition DisordersPsychologyManiaBiomarkersClinical psychologyProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Self-Reported Cognitive Failures

2010

Investigated measurement models of self-report measures of cognitive failures in 5 studies (total of 3,122 participants aged 14-70). The Cognitive Failure Questionnaire (CFQ) is a well-known and frequently used self-report measure of cognitive lapses and slips (e.g., throwing away the candy bar and keeping the wrapper). Measurement models of individual differences in cognitive failures have failed to produce consistent results so far. Therefore, in the present studies, the CFQ is compared to measures of competing measurement models: a measure of identical measurement intention (Short Inventory of Minor Lapses, SIML), a neuroticism test, a questionnaire on functional and dysfunctional self-c…

CFQForgettingPsychometricsCognitive disorderCognitionDysfunctional familyTest validitymedicine.diseaseNeuroticismDevelopmental psychologyPsychologiemedicinePsychologyBiological PsychiatryGeneral PsychologyJournal of Individual Differences
researchProduct

Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier.

2007

Cognitive deficits in multiple sclerosis (MS) are common and correlate with contemporary MRI brain abnormalities, particularly atrophy, but the ability of imaging early in the disease to predict later cognitive impairment remains to be determined. Thirty relapsing—remitting MS patients recruited within three years of the onset of the disease, and in whom MRI had been performed at baseline and a year later, were assessed neuropsychologically five years later. Imaging parameters accounting for significant variance in cognitive performance were identified using multiple regressions, once confounding variables were controlled. Patients performed significantly worse than expected on tests of at…

Cognitive deficits in multiple sclerosisAdultMalePediatricsmedicine.medical_specialtyDevelopmental psychologyCentral nervous system diseaseDisability EvaluationAtrophyDegenerative diseaseMultiple Sclerosis Relapsing-Remittingrelapsing-remitting multiple sclerosiPredictive Value of TestsmedicineHumansMultiple sclerosiCognitive impairmentMultiple sclerosisCognitive disorderCognitionMiddle Agedmedicine.diseaseMagnetic Resonance ImagingEarly DiagnosisNeurologyRelapsing remittingLinear ModelsFemaleNeurology (clinical)AtrophyPsychologyCognition DisordersFollow-Up StudiesMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct

Neuronal Bioenergetics and Acute Mitochondrial Dysfunction: A Clue to Understanding the Central Nervous System Side Effects of Efavirenz

2014

Background. Neurological pathogenesis is associated with mitochondrial dysfunction and differences in neuronal/glial handling of oxygen and glucose. The main side effects attributed to efavirenz involve the CNS, but the underlying mechanisms are unclear. Methods. Human cell lines and rat primary cultures of neurons and astrocytes were treated with clinically relevant efavirenz concentration. Results. Efavirenz alters mitochondrial respiration, enhances reactive oxygen species generation, undermines mitochondrial membrane potential, and reduces adenosine triphosphate (ATP) levels in a concentration-dependent fashion in both neurons and glial cells. However, it activates adenosine monophospha…

CyclopropanesCell SurvivalCell RespirationPharmacologyMitochondrionBiologymedicine.disease_causechemistry.chemical_compoundOxygen ConsumptionHIV-associated neurocognitive disordersSuperoxidesnitric oxideCell Line TumorneurotoxicitymedicineAnimalsHumansImmunology and AllergyGlycolysisRats WistarMembrane Potential MitochondrialNeuronsMembrane potentialDose-Response Relationship DrugNeurotoxicityHIVefavirenzmedicine.diseasecentral nervous systemAdenosineBenzoxazinesMitochondriaRatsmitochondriaInfectious Diseasesmedicine.anatomical_structurechemistrynervous systemAlkynesAstrocytesReverse Transcriptase InhibitorsNeurogliaEnergy MetabolismNeurogliaAdenosine triphosphateOxidative stressmedicine.drug
researchProduct

Mobility limitations and cognitive deficits as predictors of institutionalization among community-dwelling older people.

2006

<i>Purpose:</i> Mobility limitations and cognitive disorders have often been observed as risks for institutionalization. However, their combined effects on risk of institutionalization among initially community-dwelling older people have been less well reported. <i>Design:</i> A prospective cohort study with 10-year surveillance on institutionalization. <i>Subjects:</i> Study population (n = 476) consisted of 75- and 80-year-old people who were community-dwelling, had not been diagnosed with dementia, and participated in tests on walking speed and cognitive capacity at a research centre. <i>Measures:</i> Cognitive capacity was measured with th…

GerontologyMaleAgingcognitive deficitsInstitutionalisationMEDLINERisk AssessmentlaitoshoitoDevelopmental psychologymedicineHumansProspective StudiesMobility LimitationFinlandAgedProportional Hazards ModelsAged 80 and overPsychiatric Status Rating ScalesProportional hazards modelCognitive disorderInstitutionalizationCognitionmedicine.diseaseliikkumisrajoitteetMobility Limitationmobility limitationsinstitutionalizationFemaleGeriatrics and GerontologyPsychologyOlder peopleRisk assessmentCognition Disorderskognitiiviset häiriötGerontology
researchProduct